Literature DB >> 22854332

Diversity of antimicrobial resistance genes and class-1-integrons in phylogenetically related porcine and human Escherichia coli.

Christina Susanne Hölzel1, Katrin Susanne Harms, Johann Bauer, Ilse Bauer-Unkauf, Stefan Hörmansdorfer, Peter Kämpf, Gabriele Mölle, Cornelia Oehme, Petra Preikschat, Karin Schwaiger.   

Abstract

Antimicrobial resistant bacteria and resistance genes can be transferred between the microbial flora of humans and animals. To assess the dimension of this risk, we compared the phylogenetic ancestry of human and porcine tetracycline-insusceptible Escherichia coli. Further, we compared the resistance gene profiles (tetA/tetB/tetC/tetD/tetM/sulI/sulII/sulIII/strA-strB/addA) and the prevalence of class-1-integrons in isolates of identical and different phylogroups by endpoint-PCR. This is the first genotypic comparison of antimicrobial resistance in E. coli from humans and animals which allows for the phylogenetic ancestry of the isolates. E. coli isolates from diseased humans belonged regularly to phylogroup B2 (24.3%) or D (30.9%) and were rarely not typeable (7.2%); by contrast, isolates from pig manure were regularly not typeable (46.7%) and rarely grouped into phylogroup B2 (2.2%) or D (2.9%). Class-1-integrons were detected in 40.8% of clinical (n=152), in 9.5% of community-derived (n=21) and in 10.9% of porcine (n=137) E. coli. The prevalence of sulI (42.4%/16.0%) in phylogroup A and of tetA, tetB and sulII in phylogroup B1 differed significantly between human clinical and porcine strains. Human clinical isolates (except B2-isolates) carried significantly more different resistance genes per strain, compared to porcine or community-derived isolates. ERIC-PCR-analysis of B2- (and D-) isolates with identical genetic profiles revealed that only a minor part was clonally related. The dominant resistance gene profiles differed depending on phylogroup and source. Human and porcine isolates do not exceedingly share their genes, and might rapidly adapt their resistance gene equipment to meet the requirements of a new environment. The study underlines that resistance gene transfer between human and porcine isolates is limited, even in phylogenetically related isolates.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22854332     DOI: 10.1016/j.vetmic.2012.06.010

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  5 in total

1.  Genomic Characterization of Prevalent mcr-1, mcr-4, and mcr-5 Escherichia coli Within Swine Enteric Colibacillosis in Spain.

Authors:  Isidro García-Meniño; Dafne Díaz-Jiménez; Vanesa García; María de Toro; Saskia C Flament-Simon; Jorge Blanco; Azucena Mora
Journal:  Front Microbiol       Date:  2019-11-01       Impact factor: 5.640

2.  Multi-Locus Sequence Typing and Drug Resistance Analysis of Swine Origin Escherichia coli in Shandong of China and Its Potential Risk on Public Health.

Authors:  Wei Wang; Lanping Yu; Wenwen Hao; Fusen Zhang; Meijie Jiang; Shuping Zhao; Fangkun Wang
Journal:  Front Public Health       Date:  2021-12-02

3.  Mobile elements, zoonotic pathogens and commensal bacteria: conduits for the delivery of resistance genes into humans, production animals and soil microbiota.

Authors:  Steven P Djordjevic; Harold W Stokes; Piklu Roy Chowdhury
Journal:  Front Microbiol       Date:  2013-04-30       Impact factor: 5.640

4.  Detection and linkage to mobile genetic elements of tetracycline resistance gene tet(M) in Escherichia coli isolates from pigs.

Authors:  Sonia Jurado-Rabadán; Ricardo de la Fuente; José A Ruiz-Santa-Quiteria; José A Orden; Lisbeth E de Vries; Yvonne Agersø
Journal:  BMC Vet Res       Date:  2014-07-11       Impact factor: 2.741

5.  Microarray Evaluation of Antimicrobial Resistance and Virulence of Escherichia coli Isolates from Portuguese Poultry.

Authors:  Nuno Mendonça; Rui Figueiredo; Catarina Mendes; Roderick M Card; Muna F Anjum; Gabriela Jorge da Silva
Journal:  Antibiotics (Basel)       Date:  2016-01-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.